Clinical Trial Update: Duration of Immune Response to Influenza Vaccination in Patients With RA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing the duration of the immune response to influenza vaccination in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Bassett Healthcare | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED